Feature Image

Health Authorities in Brazil Approve Importation of RSHO™ for First Time for Multiple Sclerosis Patient

Medical Marijuana, Inc. portfolio company HempMeds® Brasil has shipped its flagship product, Real Scientific Hemp Oil™ (RSHO™), to a patient diagnosed with multiple sclerosis (MS).

This is the first time that a patient in Brazil has successfully received import authorization for CBD hemp oil for the symptoms of multiple sclerosis. However, patients in Brazil with their doctor’s prescription, regardless of their condition, can apply to ANVISA, the health authority in Brazil, for approval to import RSHO™.

Multiple sclerosis (MS) is a degenerative disease of the central nervous system that often leads to disablement. The body’s immune system mistakenly attacks and destroys the myelin sheath, the fatty substance that protects and insulates the nerve fibers. Myelin increases the speed at which electrical impulses move between the brain and the rest of the body and are essential for the nervous system to function properly. A loss of myelin causes signals between the brain and the body to become disrupted, leading to a number of possible symptoms.

Common MS symptoms include fatigue, walking difficulties, numbness, muscle spasms, weakness, vision problems, dizziness, bladder and bowel problems, pain, depression, and emotional and cognitive changes.

MS affects around 2.5 million people worldwide. In Brazil, the prevalence rate has increased over the last decade, though researchers are in disagreement as to reasons why. The upward trend seems to be concentrated in the south of the country. Caucasians are diagnosed with MS at a higher rate in the Brazil, and about 75 percent of all domestic MS cases occur in women.

There is no cure for multiple sclerosis. Treatment efforts, including the administering of corticosteroids to reduce nerve inflammation and plasma exchange, can help to manage symptoms and potentially limit the disease’s progression, but these therapies can be costly.

Current treatment options for controlling the symptoms of MS can range upwards of $40,000 BRL a year (about $20,000 in USD), making an affordable alternative for patients in Brazil an urgent priority for healthcare officials.

Patients in Brazil who have received a prescription from their doctor for CBD oil for their personal condition can apply to ANVISA for authorization to import RSHO™. If you are in Brazil and looking to purchase RSHO™ CBD oil, get started by visiting the HempMeds® Brasil Patient’s Page or contact our team at (21) 4042-2095 with any questions you might have.

Learn more about HempMeds® Brasil and the rest of the Medical Marijuana, Inc. portfolio of companies by following our news feed.

  • February 21, 2017
  • Jeffrey Stamberger